Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 840 results for "astrazeneca"

AstraZeneca delays PD-L1 data in rejig of phase 3 program

AstraZeneca refines endpoints in late-stage lung cancer studie...

AstraZeneca (NYSE: AZN ) has tweaked the endpoints of its Phase 3 clinical trial, MYSTIC, assessing durvalumab and tremelimumab for first-line treatment of patients with non-small cell lung cancer (NSCLC). The original objective was the effect on ... Seeking Alpha, 19 hours ago

629 images for astrazeneca

FierceBiotech, 16 hours ago
American Banking News, 1 day ago
SleekMoney, 21 hours ago
WKRB News, 19 hours ago
WKRB News, 20 hours ago
WKRB News, 1 day ago
Pharma Letter, 20 hours ago
World Pharma News, 4 days ago
Post Online Media, 1 week ago
Motley Fool UK, 6 days ago

Exenatide-Pioglitazone Combo Tops Insulin in Type 2 Diabetes

A combination of pioglitazone and the glucagonlike peptide 1 (GLP-1) agonist exenatide ( Bydureon , AstraZeneca) may represent an effective and safe alternative to insulin for the treatment of type 2 diabetes in patients who are poorly controlled ...
 Dermatology Online Journal16 hours ago

Astrazeneca PLC (AZN) Cut to Sell at Zacks Investment Research

Astrazeneca PLC (NYSE:AZN) was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research report issued on Tuesday. According to Zacks, AstraZeneca has a strong product portfolio and is one of the key players in the ...
 American Banking News1 day ago Astrazeneca PLC (AZN) Upgraded by Zacks Investment Research to Hold  WKRB News1 day ago Astrazeneca PLC (AZN) Short Interest Update  WKRB News1 day ago Credit Suisse Group Reaffirms Underperform Rating for AstraZeneca plc (AZN)  Ticker Report2 days ago

BRIEF-Feelgood Svenska signs deal with AstraZeneca

n"Jan 12 Feelgood Svenska AB (publ) : * Signs agreement with AstraZeneca * Agreement regards all of about 2,500 AstraZeneca employees in Göteborg Source text for Eikon: Further company coverage: (Gdynia
 Reuters UK6 days ago AstraZeneca acquires antithrombotic candidate from APT Therapeutics  Pharma Field1 week ago AstraZeneca taps APT in latest deal  BioPharma Dive1 week ago AstraZeneca acquires biotech's unique antithrombotic drug  Pharmafile1 week ago

Drug shares tumble on Trump's talk of price controls

Trump just created a big headache for Big Pharma. Shares of drug giants including Pfizer, Bristol-Myers Squibb and AstraZeneca plummeted late Wednesday morning after President-elect Donald Trump criticized the industry and suggested putting in ...
 New York Post6 days ago 5 Trump-Proof Pharma Dividend Stocks to Buy  Nasdaq15 hours ago The pharma week in review  FirstWord Pharma2 days ago Donald Trump vs. Big Pharma: He can't bring down prescription drug costs alone  Salon3 days ago

March 3rd Options Now Available For AstraZeneca

 Forbes.com5 days ago

Wuxi works with medical giant to foster IoT health system

AstraZeneca will provide patients with a comprehensive health management process covering prevention, diagnosis and follow-up tracking. [Photo provided to China Daily] AstraZeneca China, a multinational pharmaceutical giant, has unveiled its ... days ago

Bristol-Myers, Astrazeneca Take Beating in Wake of Merck's Latest Drug Approval

Leerink analyst Seamus Fernandez wrote that the news "comes as a significant surprise" and gives Merck "another leg up" in the race to develop
 Yahoo! Finance6 days ago Bristol-Myers and AstraZeneca Take Beatings  Yahoo! Finance6 days ago
Motley Fool UK

Will Vectura Group plc outperform AstraZeneca plc after today's results gain a Brexit boost?

Inhaled airways disease specialist Vectura (LSE: VEC) has released an impressive update today. It shows that the company has made good progress in the first nine months of the year and has the potential to deliver improved performance in future. But ...
 Yahoo! Finance UK and Ireland6 days ago

Shell, AstraZeneca Could Surprise in 2017, Credit Suisse Says

AstraZeneca and Royal Dutch Shell will surprise investors. Investment bank Credit Suisse kicked off the year by naming two potential "surprise" stocks for 2017. Both these stocks could suddenly shoot higher this year, rewarding investors ...
 TheStreet.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less